Diagnosis of Alport syndrome--search for proteomic biomarkers in body fluids (Q40119584)

17 September 2017

Diagnosis of Alport syndrome--search for proteomic biomarkers in body fluids (English)

1 reference

17 September 2017

0 references

1 reference

Michael Pohl

1

1 reference

17 September 2017

Karin Danz

2

1 reference

17 September 2017

Oliver Gross

3

1 reference

17 September 2017

Ulrike John

4

1 reference

17 September 2017

Johannes Urban

5

1 reference

17 September 2017

Ludwig Patzer

6

1 reference

17 September 2017

Sandra Habbig

7

1 reference

17 September 2017

Markus Feldkötter

8

1 reference

17 September 2017

Oliver Witzke

9

1 reference

17 September 2017

Mario Walther

10

1 reference

17 September 2017

Heidrun Rhode

11

1 reference

17 September 2017

23 June 2013

1 reference

17 September 2017

1 reference

17 September 2017

28

1 reference

17 September 2017

2117-2123

1 reference

17 September 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-013-2533-5

17 September 2017

0 references

cites work

Inherited diseases of the glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Novel COL4A4 splice defect and in‐frame deletion in a large consanguine family as a genetic link between benign familial haematuria and autosomal Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Cystic and inherited kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Renal diseases associated with hematuria in children and adolescents: a brief tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Familial hematuria due to type IV collagen mutations: Alport syndrome and thin basement membrane nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Evaluation of lenticonus in Alport's syndrome: quantitative Scheimpflug analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Alport syndrome and thin basement membrane nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Glomerular pathology in Alport syndrome: a molecular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Urinary excretion of glomerular basement membrane antigens in Alport's syndrome. A new diagnostic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Searching biomarker candidates in serum using multidimensional native chromatography. II Method evaluation with Alport syndrome and severe inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

ADAMs: modulators of cell–cell and cell–matrix interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

The role of ADAM-mediated shedding in vascular biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

An update on the pathomechanisms and future therapies of Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2533-5

Diagnosis of Alport syndrome without biopsy?

21 January 2018

1 reference

12 December 2020

Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders

1 reference

12 December 2020

Alport syndrome. Molecular genetic aspects

1 reference

12 December 2020

[Urinary excretion of acid glycosaminoglycans and glomerular basement membrane antigens in patients with Alport's Syndrome (author's transl)]

1 reference

12 December 2020

X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.

1 reference

12 December 2020

Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants

1 reference

12 December 2020

Clinical utility gene card for: Alport syndrome

1 reference

12 December 2020

Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial

1 reference

12 December 2020

Genetic disorders of glomerular basement membranes

1 reference

12 December 2020

Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients

1 reference

12 December 2020

10.1007/S00467-013-2533-5

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference